13F

APGE APOGEE THERAPEUTICS INC

2026Q1 · CUSIP 03770N101 · Sector: Healthcare & Biotech

Lit · Institutions accelerating in
Holders
223
Δ holders QoQ
+16
Breadth percentile
Top 19%
Whale holders
129
Δ whales
+16
Inst. holding value
$6.5B
New positions
49
Closed positions
33
Price momentum (1Q)
+13.1%
Put / Call
8/9

Breadth history (34 quarters)

2023Q4: Δ+13 · h=86 2024Q1: Δ+52 · h=138 2024Q2: Δ+2 · h=140 2024Q3: Δ+0 · h=140 2024Q4: Δ+19 · h=159 2025Q1: Δ+12 · h=171 2025Q2: Δ+12 · h=183 2025Q3: Δ-9 · h=174 2025Q4: Δ+33 · h=207 2026Q1: Δ+16 · h=223 2023Q4: holders=86 2024Q1: holders=138 2024Q2: holders=140 2024Q3: holders=140 2024Q4: holders=159 2025Q1: holders=171 2025Q2: holders=183 2025Q3: holders=174 2025Q4: holders=207 2026Q1: holders=223 -52 -26 +0 +26 +52 77156235 23Q424Q124Q224Q324Q425Q125Q225Q325Q426Q1 Δ holders (bar) Holders (line)

Past Lit Events & Aftermath 3 lit events

Period Percentile Next-1Q return Next-2Q return
2026Q1 Top 19%
2025Q4 Top 16% +13.1%
2024Q1 Top 4% -0.5% -6.1%

Options Sentiment

Put holders
8
QoQ: +4
Call holders
9
QoQ: +4

See methodology →

Fundamentals

PE (TTM)
EPS (TTM)
$-4.33
EPS YoY
Revenue (TTM)
Revenue YoY
Quarterly Revenue & EPS (4Y)
2023-09-30: EPS -0.51 2024-03-31: EPS -0.64 2024-06-30: EPS -0.60 2024-09-30: EPS -0.86 2024-12-31: EPS -1.20 2025-03-31: EPS -0.95 2025-06-30: EPS -1.13 2025-09-30: EPS -1.11 2025-12-31: EPS -1.03 2026-03-31: EPS -1.06 -1.32 -0.66 0.00 20222023202420252026 EPS

Quarterly figures; EPS split-adjusted, early quarters hidden when not calibrable

As of 2026-03-31 · SEC filings (XBRL)